FDA Investigator: Mihaly Ligmond

- Mihaly Ligmond first started conducting FDA inspections in 2000, with the last inspection in 2020. Over that time, Mihaly Ligmond has conducted 186 inspections at 123 companies across 145 sites.

Documents

FDA 483 GSK Vaccines, Marburg | May 2018

Available - $199
Mihaly Ligmond
Biologic Form 483

FDA 483 OMRIX Biopharmaceuticals LTD, Nes-Ziona | 2020

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Organon Teknika Corporation LLC, Durham | 2020

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 MSD International GmbH T/A MSD Ireland (Carlow), Carlow | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Pfizer Ireland Pharmaceuticals, Dublin 22 | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Bio-Rad Laboratories, Inc., Woodinville | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Seqirus Vaccines Limited, Liverpool | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Catalent Belgium SA, Brussels | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 NAMSA SAS, Chasse Sur Rhone | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Sanofi Pasteur SA, Marcy L Etoile | 2019

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Novartis Pharma Stein AG, Stein Ag | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Jubilant HollisterStier LLC, Spokane | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Pfizer Ireland Pharmaceuticals, Dublin 22 | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Sanquin Plasma Products B.V., Amsterdam | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Plasma Industries Belgium (PIBe), Brussels | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Dendreon Pharmaceuticals LLC, Seal Beach | 2018

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Vetter Pharma Fertigung GmbH & Co. KG, Langenargen | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Vetter Pharma Fertigung GmbH & Co. KG, Ravensburg | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Bloodworks, Seattle | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Catalent Belgium SA, Brussels | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals, Dresden | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Merck Sharp & Dohme Corp., West Point | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Biovex Incorporated, Woburn | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Bio-Rad Medical Diagnostics GmbH, Dreieich | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Octapharma Pharmazeutika Produktions GmbH, Vienna | 2017

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Grifols Therapeutics Inc., Clayton | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Roche Singapore Technical Operations Pte. Ltd., Singapore | 2016

Out-of-stock
Mihaly Ligmond
Human Drug Form 483

FDA 483 Seqirus Pty Ltd, Parkville | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Allergy Laboratories, Inc., Oklahoma City | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Nelson Laboratories, Inc., Salt Lake City | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

FDA 483 Micro Typing Systems, Inc., Pompano Beach | 2016

Out-of-stock
Mihaly Ligmond
Biologic Form 483

Co-Investigators (84)